title: Genital erythrodysesthesia as a severe manifestation of capecitabine therapy: a report of 3 cases.
authors.forename: Beatriz
authors.initials: B
authors.lastname: Fleta-Asín
authors.forename: Javier
authors.initials: J
authors.lastname: Alcántara-González
authors.forename: Leticia
authors.initials: L
authors.lastname: Alonso-Castro
authors.forename: Mayte
authors.initials: M
authors.lastname: Truchuelo-Díez
authors.forename: Pedro
authors.initials: P
authors.lastname: Jaén-Olasolo
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D004890:Erythema / Q000139:chemically induced*; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D005832:Genital Diseases, Male / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D008297:Male; D010292:Paresthesia / Q000139:chemically induced*; D012611:Scrotum / Q000473:pathology
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil